A Designer Nanoparticle Platform for Controlled Intracellular Delivery of Bioactive Macromolecules: Inhibition of Ubiquitin-Specific Protease 7 in Breast Cancer Cells

[Image: see text] Biological therapeutics represent an increasing and critical component of newly approved drugs; however, the inability to deliver biologics intracellularly in a controlled manner remains a major limitation. We have developed a semi-synthetic, tunable phage-like particle (PLP) platf...

Descripción completa

Detalles Bibliográficos
Autores principales: McClary, Wynton D., Catala, Alexis, Zhang, Wei, Gamboni, Fabia, Dzieciatkowska, Monika, Sidhu, Sachdev S., D’Alessandro, Angelo, Catalano, Carlos E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295703/
https://www.ncbi.nlm.nih.gov/pubmed/35796308
http://dx.doi.org/10.1021/acschembio.2c00256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295703/
https://www.ncbi.nlm.nih.gov/pubmed/35796308
http://dx.doi.org/10.1021/acschembio.2c00256

Ejemplares similares